Go to the list of all blogs
Rick Johnson's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
TOMI Environmental Solutions (TOMZ): A Closer Look at This Specialized Disinfection Technology Play

TOMI Environmental Solutions (TOMZ): A Closer Look at This Specialized Disinfection Technology Play

Key Takeaways

  • TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) is a small-cap disinfection and decontamination technology company headquartered in Frederick, Maryland.
  • The company's flagship product is SteraMist, which uses its patented and registered Binary Ionization Technology (BIT) to deliver a low-concentration hydrogen peroxide-based mist or fog.
  • It operates across four main segments: Hospital-HealthCare, Life Sciences, Commercial, and Food Safety.
  • As a micro-cap company, TOMZ carries elevated volatility, liquidity, and execution risk relative to larger, more established peers.
  • The company generates revenue primarily from the sale of SteraMist equipment and related consumables and services.

Introduction: Understanding the TOMZ Story

TOMI Environmental Solutions, Inc. develops and sells disinfection and decontamination technology aimed at controlling bacteria, viruses, and other pathogens in indoor air and on surfaces. I follow TOMZ because its core technology addresses hygiene and biosecurity needs across healthcare, pharmaceutical, food production, and commercial settings. The company is best known for its SteraMist brand, built around a proprietary hydrogen peroxide-based application method. To get a quick sense of its positioning, I also checked this using Tickeron’s AI Screener to compare it with peers in the broader industry.

Company Overview and Business Model

TOMI Environmental Solutions traces its roots to 1979 and is headquartered in Frederick, Maryland, where it operates with a relatively small team of roughly 20 employees. The company is led by Chief Executive Officer Halden Stuart Shane. As a micro-cap issuer listed on the Nasdaq, TOMZ represents a small company by market value, which is an important consideration for investors evaluating its risk profile.

The company's business model centers on a single core technology platform. SteraMist uses Binary Ionization Technology (BIT), a patented process that converts a low-percentage hydrogen peroxide solution into a fine mist or fog. This application method is designed to disinfect and decontaminate air and surfaces efficiently while using a lower concentration of hydrogen peroxide than some traditional approaches. TOMI markets a range of hardware products built around this technology, including portable and stationary systems for different environments.

TOMI organizes its commercial activities into four primary business segments: Hospital-HealthCare, Life Sciences, Commercial, and Food Safety. These segments reflect the company's efforts to serve diverse end markets, from hospital rooms and pharmaceutical cleanrooms to food processing facilities and general commercial spaces. Revenue is generated through the sale of SteraMist equipment, related consumables, and associated service offerings.

Market Position and Competitive Landscape

Within the broader disinfection and infection-control industry, TOMZ competes with larger, better-capitalized providers of cleaning, sanitization, and decontamination solutions. The company differentiates itself through its proprietary Binary Ionization Technology and its focus on hydrogen peroxide-based applications that aim to reduce chemical residue and environmental impact compared with certain alternatives. However, its small size and limited workforce mean it must compete on technology differentiation and niche applications rather than scale.

The company serves both domestic and international customers and has described efforts to expand its regulatory approvals in markets such as Europe. Its positioning in regulated environments—including healthcare and life sciences—means that certifications and compliance approvals can serve as meaningful competitive milestones for the business.

Why Investors Follow TOMZ

Investor interest in TOMZ is driven by several long-term themes. First, heightened awareness of biosecurity, infection prevention, and environmental decontamination has supported demand for technologies like SteraMist across healthcare and food safety settings. Second, the company's proprietary technology provides a potential competitive moat in a specialized niche, and it has pursued certifications and regulatory approvals that could open access to additional markets such as pharmaceutical cleanrooms.

Third, the company's focus on a lower-concentration, environmentally friendlier hydrogen peroxide solution aligns with broader sustainability trends in industrial hygiene. These factors give TOMZ a distinct—if small—market position that attracts attention from investors interested in specialized technology plays. It is important to note, however, that the company's financial profile remains that of an early-stage growth business, and investors often weigh its technology narrative against its modest scale and historical profitability.

Risks and Important Considerations

Investing in TOMZ carries several notable risks. As a micro-cap company with a small number of employees, the business has limited operational scale and may be more sensitive to the loss of key customers or personnel. Customer concentration, dependence on a single core technology, and competition from larger, well-funded rivals are ongoing considerations. The company's financial profile has historically reflected a growth-stage business, and its ability to achieve consistent profitability is not guaranteed.

Macroeconomic sensitivity is another factor: capital-equipment purchasing in healthcare, life sciences, and food production can fluctuate with broader economic conditions and customer budgets. Regulatory factors also matter, since sales into healthcare and cleanroom markets depend on obtaining and maintaining certifications. Finally, corporate actions such as capital-raising or restructuring—common among small issuers—can affect shareholder value and warrant careful review of the company's filings.

Using AI Tools for Deeper Analysis

In my research process, I often turn to Tickeron’s AI Screener to evaluate specialized names like TOMZ against broader industry benchmarks. This AI-powered platform helps identify opportunities using technical indicators, fundamentals, volatility, trends, AI-generated signals, industries, price patterns, and customizable filters. It allows users to efficiently screen thousands of stocks and ETFs to match their own investment strategies, which can be especially useful when assessing micro-cap opportunities in niche sectors.

Conclusion

TOMI Environmental Solutions occupies a specialized position in the disinfection and decontamination market, anchored by its proprietary SteraMist technology and Binary Ionization Technology platform. Its focus on healthcare, life sciences, commercial, and food safety applications gives the company a diversified set of end markets, even as its small size defines a distinct risk profile. For investors, TOMZ represents a niche, technology-driven micro-cap with a recognizable brand and exposure to long-running themes in biosecurity and environmental hygiene.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TOMZ

TOMZ saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for TOMZ moved out of overbought territory on November 18, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 53 similar instances where the indicator exited the overbought zone. In 49 of the 53 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for TOMZ moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 26 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TOMZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

TOMZ broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on TOMZ as a result. In 68 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for TOMZ just turned positive on October 27, 2026. Looking at past instances where TOMZ's MACD turned positive, the stock continued to rise in 34 of 44 cases over the following month. The odds of a continued upward trend are 77%.

TOMZ moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TOMZ crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +22.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where TOMZ advanced for three days, in 175 of 229 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

The Aroon Indicator entered an Uptrend today. In 85 of 119 cases where TOMZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. TOMZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.229) is normal, around the industry mean (10.189). P/E Ratio (-4.125) is within average values for comparable stocks, (-16.372). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (0.975). Dividend Yield (0.000) settles around the average of (0.050) among similar stocks. P/S Ratio (1.637) is also within normal values, averaging (251.106).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TOMZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Industry description

Companies in the industrial specialties industry process basic materials and minerals into various specialty products, such as flat and safety glass, fire retardant products, paints and coatings. Examples of companies operating in this industry are Sherwin-Williams Company, PPG Industries, Inc. and RPM International Inc.

Market Cap

The average market capitalization across the Industrial Specialties Industry is 2.37B. The market cap for tickers in the group ranges from 281.2K to 28.55B. VLTO holds the highest valuation in this group at 28.55B. The lowest valued company is FLMP at 281.2K.

High and low price notable news

The average weekly price growth across all stocks in the Industrial Specialties Industry was -2%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -25%. RAIN experienced the highest price growth at 100%, while LIQT experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Industrial Specialties Industry was 49%. For the same stocks of the Industry, the average monthly volume growth was 57% and the average quarterly volume growth was 65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 51
Price Growth Rating: 64
SMR Rating: 88
Profit Risk Rating: 92
Seasonality Score: -28 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry IndustrialSpecialties

Industry
N/A
Address
8430 Spires Way
Phone
+1 800 525-1698
Employees
20
Web
https://www.tomimist.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.